利莫氨酸通过调节MAPK通路来增加KHYG-1细胞对K562细胞的细胞毒性
Ming-Ju Hsieh1,2,3, Jen-Tsun Lin4, Yi-Ching Chuang1
1Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
Environmental toxicology
|August 16, 2023
概括
利莫氨酸通过增强细胞毒性分子和诱导白血病细胞的亡来增强自然杀手 (NK) 细胞杀死癌症的能力. 这种化合物显示出改善NK细胞基癌症免疫疗法策略的前景.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 自然杀手 (NK) 细胞对于癌症免疫疗法至关重要.
- 像KHYG-1和K562这样的白血病细胞系用于研究NK细胞活性.
- 黄醇化合物正在研究其治疗潜力.
研究的目的:
- 为了研究黄醇利莫西特林对NK细胞细胞毒性的作用.
- 确定林氏素如何增强KHYG-1细胞对K562细胞的抗白血病活性.
主要方法:
- 治疗KHYG-1细胞时使用了limocitrin.
- 分析了细胞毒性分子 (перфорин,花粉酶,花粉素) 的表达水平.
- 评估了与亡相关的蛋白质 (t-Bid,caspase 3,PARP) 和DNA修复蛋白质 (SET,Ape1).
- 测量了转录因子 (CREB) 和激酶 (ERK,p38,JNK) 的酸化.
主要成果:
- 利莫林通过CREB酸化在KHYG-1细胞中增加了穿孔素,A粒酶,B粒酶和花粉素的表达.
- 利莫素通过上调t-Bid,分裂caspase3和分裂PARP来诱导K562细胞亡.
- 利莫素通过降低SET和Ape1来抑制K562细胞中的DNA修复,从而导致酶独立的细胞死亡.
- 利莫林通过ERK,p38和JNK酸化在KHYG-1细胞中增强了大酶B的表达.
结论:
- 利莫素显著增强NK细胞对白血病细胞的细胞毒性活性.
- 利莫氨酸采用多种机制,包括诱导亡和抑制DNA修复,以杀死癌细胞.
- 利莫氨酸代表了增强NK细胞基癌症免疫疗法的潜在治疗剂.
相关概念视频
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
MAPK Signaling Cascades
5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cytotoxic T Cells-mediated Immune Response
971
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
971


